Tag: solution

VANCOUVER, British Columbia, July 29, 2025 (GLOBE NEWSWIRE) -- ZenaTech, Inc. (Nasdaq: ZENA) (FSE: 49Q) (BMV: ZENA) ("ZenaTech"), a business technology solution provider specializing in AI (Artificial Intelligence) drones, Drone as a Service (DaaS), Enterprise SaaS, and Quantum Computing solutions, today announces the formation of Zena AI, Inc. (Zena AI), an AI Development Center part of its ZenaDrone US drone company subsidiary. Zena AI will be focused on building advanced artificial intelligence software solutions for the US Department of Defense and Homeland Security agencies. The announcement comes in response to the White House’s AI Action Plan and related Executive Orders released on July 23^rd that set a nationwide agenda for accelerating American-made AI systems across federal and defense sectors and boosting global exports.

FREMONT, Calif., July 29, 2025 (GLOBE NEWSWIRE) -- Enphase Energy, Inc. (NASDAQ: ENPH), a global energy technology company and the world's leading supplier of microinverter-based solar and battery systems, today announced the launch of the 4th-generation Enphase^® Energy System, featuring the IQ^® Battery 10C, IQ^® Meter Collar, and the IQ^® Combiner 6C. This next-generation system stands out for its smaller footprint, enhanced features, easier installation, and unmatched reliability. Watch a video about the new Enphase system here.

ORMOND BEACH, Fla., July 29, 2025 (GLOBE NEWSWIRE) -- PlanetBids (or “the Company”), a provider of procurement software as a service (SaaS) solutions, today announced the appointment of Kaleb Boudreaux as Senior Vice President of Finance, reporting to CEO David DiGiacomo. Mr. Boudreaux will be responsible for overseeing the Company’s financial health, driving strategic growth, and advising executive leadership on investment strategies, cost optimization, and risk management. PlanetBids is backed by Capstreet, a Houston-based lower middle market private equity firm.

MUNICH, July 29, 2025 (GLOBE NEWSWIRE) -- Meliodays Medical and Celanese Corporation (NYSE: CE) have signed an agreement related to Meliodays’ pre-clinical development of MelioOne^®, the first hormone-free non-contraceptive intrauterine device (IUD) designed to deliver localized relief for menstrual pain. MelioOne^® combines the proven VitalDose^® Drug Delivery Platform from Celanese with Meliodays’ innovative IUD design and non-hormonal active pharmaceutical ingredient (API).